2 cheap FTSE 250 shares to buy for July

As the economy reopens, these two FTSE 250 stocks look attractive from a valuation and growth perspective, says this Fool, who’d buy both.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

As we enter the second half of the year, I’ve been looking for FTSE 250 value stocks to add to my portfolio, which could increase profitability as the world moves on from the coronavirus pandemic. 

I’d buy both these cheap FTSE 250 shares based on their current valuation and growth prospects. 

Cheap FTSE 250 shares 

The first stock on my list is public transport operator FirstGroup (LSE: FGP). Over the past year, as consumers have been repeatedly told to stay at home and avoid travelling, public transport use has plunged. This has had a severe impact on the company’s sales and profits. 

According to its half-year results for the six months to the end of September 2020, the company reported an adjusted operating profit of just £10m. However, the figures were skewed by a £33.2m benefit relating to the termination of its Avanti Rail contract. In the prior-year period, it earned £89m.

Management has pulled out all of the stops over the past 14 months to reinforce the group’s balance sheet and prevent further losses. These actions include the decision to sell its US bus divisions for £3.3bn. The company has also been trying to sell its Greyhound US intercity bus service. 

I think these moves should stabilise the group’s balance sheet and put the company on a stable footing to return to growth. Indeed, I believe that despite the pandemic, demand for public transport will only increase as the government tries to get people out of cars and onto more efficient forms of public transportation. 

As such, while the FTSE 250 group has struggled over the past 14 months, I’d buy the stock for the long term

That said, public transport can be a challenging industry in which to operate. Profit margins are slim, and the sector is heavily regulated. These challenges may hold back growth. There’s also a chance the company’s growth may come under pressure if it fails to win contracts. 

Growth and income

The other FTSE 250 stock I’d buy in July is CMC Markets (LSE: CMCX). This financial services company reported a record increase in profits last year. The combination of increased market volatility and stuck-at-home traders with little else to do helped the firm’s top and bottom lines. 

Profits hit £178m last year. Unfortunately, this boom is unlikely to last. Net income will decline to £104m this year, according to City projections. Still, even at this level, the stock is trading at a forward price-to-earnings (P/E) multiple of just 12.5. I think that looks cheap. 

What’s more, it offers a dividend yield of 4%. Based on these qualities, I’d buy the FTSE 250 stock today. 

Like most financial operations, regulatory risk is a key challenge the group has to deal with. If it falls foul of regulators, it could lose access to key markets, which would significantly impact revenue and profit generation. This is probably the most considerable risk hanging over the stock today. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »

Young black woman using a mobile phone in a transport facility
Market Movers

Meta stock slumps 13% after poor results. Here’s what I’ll do

Jon Smith flags up the reasons behind the fall in the Meta stock price overnight, along with his take on…

Read more »

Young Caucasian girl showing and pointing up with fingers number three against yellow background
Investing Articles

3 FTSE stocks I wouldn’t ‘Sell in May’

If the strategy had any merit in the past, I see no compelling evidence it's a smart idea today. Here…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Down 21% and yielding 10%, is this income stock a top contrarian buy now?

Despite its falling share price, this Fool reckons he's found an income stock that could be worth taking a closer…

Read more »